Analyze Diet

Topic:Pharmaceuticals

Pharmaceuticals in equine medicine encompass a wide range of drugs and therapeutic agents used to treat various conditions in horses. These substances include analgesics, anti-inflammatories, antibiotics, sedatives, and anthelmintics, among others. Each class of pharmaceuticals is designed to address specific health issues, such as pain management, infection control, or parasitic infestations. The pharmacokinetics and pharmacodynamics of these drugs can vary significantly between horses and other species, necessitating careful consideration of dosage and administration methods. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, safety, and regulatory aspects of pharmaceuticals used in equine healthcare.
Scopolamine in racing horses: trace identifications associated with dietary or environmental exposure.
Veterinary journal (London, England : 1997)    December 14, 2013   Volume 199, Issue 3 324-331 doi: 10.1016/j.tvjl.2013.12.013
Brewer K, Dirikolu L, Hughes CG, Tobin T.Scopolamine (L-hyoscine) identifications, often in small-number clusters, have been reported worldwide in performance horses over the last 30 years. Scopolamine is an Association of Racing Commissioners International (ARCI) class 3, penalty class B, substance with potential to affect performance. As such, scopolamine identification(s) in race or performance horses can result in significant penalties for the connections of the horse(s). Reviewed here is the worldwide distribution of scopolamine containing plants (primarily Datura spp.), with estimates of their potential toxicity to horses throu...
Detection and quantification of dermorphin and selected analogs in equine urine.
Bioanalysis    December 11, 2013   Volume 5, Issue 24 2995-3007 doi: 10.4155/bio.13.281
Richards SL, Cawley AT, Raftery MJ.Dermorphin, a hepta-peptide with potent analgesic properties, is classified as a doping agent in equine racing. Since its discovery, a number of biologically active structural analogs have been synthesized and made commercially available so there is a need for reliable methods of detection. Results: A sensitive detection method was developed for dermorphin and six analogs in equine urine. Peptide enrichment was achieved using weak cation exchange with subsequent separation and detection by nano-UHPLC-MS/MS. Method validation parameters included: specificity, linearity (5-10000 pg/ml), recovery...
Pharmacokinetics and physiological effects of repeated oral administrations of tramadol in horses.
Journal of veterinary pharmacology and therapeutics    November 4, 2013   Volume 37, Issue 3 269-278 doi: 10.1111/jvp.12086
Guedes AG, Knych HK, Soares JH, Brosnan RJ.This study evaluated the pharmacokinetics and physiological effects of tramadol during repeated oral administrations in horses. Nine adult healthy horses were administered tramadol at 5 and 10 mg/kg orally every 12 h for 5 days in a randomized, crossover design with a 3-week washout between treatments. Plasma concentrations of tramadol, O- and N-desmethyltramadol (M1 and M2) were measured using Liquid-Chromatography-Mass Spectrometry at predetermined time points following each tramadol administration. Cardiovascular, respiratory and gastrointestinal physiological variables were monitored an...
A generic screening methodology for horse doping control by LC-TOF-MS, GC-HRMS and GC-MS.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    October 16, 2013   Volume 941 69-80 doi: 10.1016/j.jchromb.2013.10.008
In the present study a general screening protocol was developed to detect prohibited substances and metabolites for doping control purposes in equine sports. It was based on the establishment of a unified sample preparation and on the combined implementation of liquid and gas chromatographic MS analysis. The sample pretreatment began with two parallel procedures: enzymatic hydrolysis of sulfate and glucuronide conjugates, and methanolysis of the 17β-sulfate steroid conjugates. The extracts were treated for LC-TOF-MS, GC-HRMS and GC-MS assays. The majority of the prohibited substances were ide...
Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals.
Journal of veterinary pharmacology and therapeutics    October 8, 2013   Volume 37, Issue 3 243-251 doi: 10.1111/jvp.12082
Hovanessian N, Davis JL, McKenzie HC, Hodgson JL, Hodgson DR, Crisman MV.The purpose of this study was to determine the pharmacokinetics and safety profile of firocoxib in neonatal foals. Seven healthy foals were administered 0.1 mg/kg firocoxib orally q24 h for nine consecutive days, commencing at 36 h of age. Blood was collected for firocoxib analysis using high-pressure liquid chromatography with fluorescence detection at 0 (dose #1 only), 0.25, 0.5, 1, 2, 4, 8, 16, and 24 h after doses 1, 5, and 9. For all other doses (2, 3, 4, 6, 7, and 8), blood was collected immediately prior to the next dose (24 h trough). Elimination samples (36, 48, 72, 96, 120, and 1...
Pharmacokinetics and safety of silibinin in horses.
American journal of veterinary research    September 27, 2013   Volume 74, Issue 10 1327-1332 doi: 10.2460/ajvr.74.10.1327
Hackett ES, Mama KR, Twedt DC, Gustafson DL.To determine the oral bioavailability, single and multidose pharmacokinetics, and safety of silibinin, a milk thistle derivative, in healthy horses. Methods: 9 healthy horses. Methods: Horses were initially administered silibinin IV and silibinin phospholipid orally in feed and via nasogastric tube. Five horses then consumed increasing orally administered doses of silibinin phospholipid during 4 nonconsecutive weeks (0 mg/kg, 6.5 mg/kg, 13 mg/kg, and 26 mg/kg of body weight, twice daily for 7 days each week). Results: Bioavailability of orally administered silibinin phospholipid was 0.6% PO in...
Quantitation of fluphenazine in equine serum following fluphenazine decanoate administration.
Journal of analytical toxicology    August 28, 2013   Volume 37, Issue 8 594-599 doi: 10.1093/jat/bkt073
Costello S, Heffron B, Taddei L, Benoit M, Hurt L, Simpson L, Bishop J, Folker-Calderon D, Negrusz A.Fluphenazine, a potent antipsychotic used to treat schizophrenia in humans, is used in racehorses as a performance-enhancing drug, and for that reason it has been banned by the Association of Racing Commissioners International. A liquid chromatography-tandem mass spectrometry method for detecting and quantitating fluphenazine in equine serum was developed and validated. The method was then employed to quantitate fluphenazine in serum samples collected from three study horses after intramuscular injection of fluphenazine decanoate. Stability testing showed that fluphenazine is stable in unextra...
Quantification of several acidic drugs in equine serum using LC-MS-MS.
Journal of analytical toxicology    August 27, 2013   Volume 37, Issue 8 600-604 doi: 10.1093/jat/bkt069
Heffron B, Taddei L, Benoit M, Negrusz A.The use of nonsteroidal antiinflammatory drugs in racehorses is allowed under most jurisdictions. Furosemide is administered to treat exercise-induced pulmonary hemorrhage. To help distinguish between therapeutic and illegal uses, racing regulatory bodies have set thresholds in serum for several drugs. The method for the simultaneous detection and quantification of furosemide, flunixin, ketoprofen, phenylbutazone and oxyphenbutazone using 500 µL of serum, and liquid extraction using diethyl ether : hexanes : dichloromethane followed by liquid chromatography tandem mass spectrometry quantitati...
[New drugs for horses and production animals in 2012].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    August 21, 2013   Volume 41, Issue 4 247-252 
Emmerich IU.In 2012, two newly developed active pharmaceutical ingredients for horses and food producing animals were released on the German market for veterinary drug products. Those are the parenterally applicable first generation cephalosporin Cefalonium (Cepravin®) and the nonsteroidal anti-inflammatory drug Suxibuzone (Danilon®). Furthermore, one established veterinary active pharmaceutical ingredient is applicable to additional species: The anticoccidial Amprolium (Eimeryl®) has again been authorized for chicken and turkeys. Additionally, two veterinary drugs with a new formulation as well as thr...
A clinician’s guide to factors affecting withdrawal times for equine therapeutic medications.
Veterinary journal (London, England : 1997)    August 6, 2013   Volume 198, Issue 2 313-321 doi: 10.1016/j.tvjl.2013.07.002
Tobin T, Dirikolu L, Brewer K, Hughes CG.Equine forensic science can now detect concentrations down to 25 femtograms/mL (parts per quadrillion, ppq) or less in blood and urine. As such, horsemen are increasingly at risk of inadvertent 'positives' due to therapeutic medication 'overages' or trace identifications of dietary or environmental substances. Reviewed here are the factors which determine detection times and 'withdrawal times' for substances administered to horses. Withdrawal times are affected by many factors, including dose, formulation, route and frequency of administration, bioavailability, plasma half-life, sensitivity of...
Analysis of activated platelet-derived growth factor β receptor and Ras-MAP kinase pathway in equine sarcoid fibroblasts.
BioMed research international    July 11, 2013   Volume 2013 283985 doi: 10.1155/2013/283985
Altamura G, Corteggio A, Nasir L, Yuan ZQ, Roperto F, Borzacchiello G.Equine sarcoids are skin tumours of fibroblastic origin affecting equids worldwide. Bovine papillomavirus type-1 (BPV-1) and, less commonly, type-2 are recognized as etiological factors of sarcoids. The transforming activity of BPV is related to the functions of its major oncoprotein E5 which binds to the platelet-derived growth factor β receptor (PDGFβR) causing its phosphorylation and activation. In this study, we demonstrate, by coimmunoprecipitation and immunoblotting, that in equine sarcoid derived cell lines PDGFβR is phosphorylated and binds downstream molecules related to Ras-mitoge...
Investigations into the feasibility of routine ultra high performance liquid chromatography-tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds.
Analytica chimica acta    June 10, 2013   Volume 787 163-172 doi: 10.1016/j.aca.2013.05.058
Gray BP, Viljanto M, Bright J, Pearce C, Maynard S.The detection of the abuse of anabolic steroids in equine sport is complicated by the endogenous nature of some of the abused steroids, such as testosterone and nandrolone. These steroids are commonly administered as intramuscular injections of esterified forms of the steroid, which prolongs their effects and improves bioavailability over oral dosing. The successful detection of an intact anabolic steroid ester therefore provides unequivocal proof of an illegal administration, as esterified forms are not found endogenously. Detection of intact anabolic steroid esters is possible in plasma samp...
Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses.
Veterinary journal (London, England : 1997)    May 27, 2013   Volume 196, Issue 3 294-303 doi: 10.1016/j.tvjl.2013.04.019
Lees P, Toutain PL.The presence of horse meat in food products destined for human consumption and labelled as beef has raised several concerns of public interest. This review deals solely with one aspect of these concerns; samples of equine tissue from horses destined for the human food chain have tested positive for the non-steroidal anti-inflammatory drug, phenylbutazone. The safety of some or all such foods for human consumers is a major concern, because it was shown many years ago that phenylbutazone therapy in humans can be associated with life threatening blood dyscrasias. As an initial basis for assessing...
Shutting the stable door after the horse (on phenylbutazone) has bolted.
Veterinary journal (London, England : 1997)    May 23, 2013   Volume 196, Issue 3 273-274 doi: 10.1016/j.tvjl.2013.05.001
Higgins A.No abstract available
In vitro diazepam metabolism in horses.
The Japanese journal of veterinary research    May 2, 2013   Volume 61 Suppl S82-S84 
Hayami A, Darwish WS, Ikenaka Y, Nakayama SM, Ishizuka M.There is little information about drug metabolism and pharmacokinetics in horses. Therefore, it is necessary to characterize the profiles of drug metabolites for the safe use of drugs. In this study, we focused on cytochrome P450 enzymes (CYPs), which represent an important enzyme group to determine pharmacological effects of drugs. We chose diazepam as the drug of choice for this study. The aim of this study was to elucidate the metabolic pathway of diazepam in horses in comparison with rats, and to clarify CYP subfamilies responsible for diazepam metabolism in horses. Our results showed tema...
Acute encephalopathy with concurrent respiratory and metabolic disturbances in first known parenteral human administration of flunixin meglumine and acepromazine maleate.
The Journal of emergency medicine    March 20, 2013   Volume 45, Issue 2 206-209 doi: 10.1016/j.jemermed.2012.11.088
Kamali MF, Wilson AC, Acquisto NM, Spillane L, Schneider SM.Flunexin is a nonsteroidal anti-inflammatory drug approved for veterinary use in horses and cattle. Acepromazine is a phenothiazine derivative used in horses, dogs, and cats. Human exposure to these substances is rare. Methods: We report a case of a human injection of two equine medications, flunixin and acepromazine, which resulted in altered mental status, respiratory alkalosis, gastrointestinal bleeding, and elevation of liver transaminases in a 43-year-old woman who worked as a horse trainer. The patient intentionally self-injected these medications and subsequently presented to the Emerge...
Metabolic studies of formestane in horses.
Drug testing and analysis    January 21, 2013   Volume 5, Issue 6 412-419 doi: 10.1002/dta.1444
Leung GN, Kwok WH, Wan TS, Lam KK, Schiff PJ.Formestane (4-hydroxyandrost-4-ene-3,17-dione) is an irreversible steroidal aromatase inhibitor with reported abuse in human sports. In 2011, our laboratory identified the presence of formestane in a horse urine sample from an overseas jurisdiction. This was the first reported case of formestane in a racehorse. The metabolism of formestane in humans has been reported previously; however, little is known about its metabolic fate in horses. This paper describes the in vitro and in vivo metabolic studies of formestane in horses, with the objective of identifying the target metabolite with the lon...
A Bayesian approach for estimating detection times in horses: exploring the pharmacokinetics of a urinary acepromazine metabolite.
Journal of veterinary pharmacology and therapeutics    January 16, 2013   Volume 36, Issue 1 31-42 doi: 10.1111/j.1365-2885.2013.01389.x
McGree JM, Noble G, Schneiders F, Dunstan AJ, McKinney AR, Boston R, Sillence M.We describe the population pharmacokinetics of an acepromazine (ACP) metabolite (2-(1-hydroxyethyl)promazine) (HEPS) in horses for the estimation of likely detection times in plasma and urine. ACP (30 mg) was administered to 12 horses, and blood and urine samples were taken at frequent intervals for chemical analysis. A bayesian hierarchical model was fitted to describe concentration-time data and cumulative urine amounts for HEPS. The metabolite HEPS was modelled separately from the parent ACP as the half-life of the parent was considerably less than that of the metabolite. The clearance (Cl/...
Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Analytical and bioanalytical chemistry    January 15, 2013   Volume 405, Issue 8 2595-2606 doi: 10.1007/s00216-012-6697-9
Kwok WH, Ho EN, Lau MY, Leung GN, Wong AS, Wan TS.In recent years, there has been an ongoing focus for both human and equine doping control laboratories on developing detection methods to control the misuse of peptide therapeutics. Immunoaffinity purification is a common extraction method to isolate peptides from biological matrices and obtain sufficient detectability in subsequent instrumental analysis. However, monoclonal or polyclonal antibodies for immunoaffinity purification may not be commercially available, and even if available, such antibodies are usually very costly. In our study, a simple mixed-mode anion exchange solid-phase extra...
Validated UHPLC-MS-MS method for rapid analysis of capsaicin and dihydrocapsaicin in equine plasma for doping control.
Journal of analytical toxicology    January 11, 2013   Volume 37, Issue 2 122-132 doi: 10.1093/jat/bks098
You Y, Uboh CE, Soma LR, Guan F, Taylor D, Li X, Liu Y, Chen J.A method involving ultra high-performance liquid chromatography-tandem mass spectrometry was developed and validated for the analysis of capsaicin and dihydrocapsaicin in equine plasma. The analytes were recovered from plasma by liquid-liquid extraction using methyl tert-butyl ether and separated on a sub-2 micron column. The mobile phase was composed of 2 mM ammonium formate and methanol. A triple quadrupole mass spectrometer was used to detect the analytes in positive electrospray ionization mode with selected reaction monitoring. The limits of detection, quantification and confirmation for ...
Misoprostol: is it safety or a lack of understanding that prevents its more frequent usage?
Equine veterinary journal    December 13, 2012   Volume 45, Issue 1 8 doi: 10.1111/evj.12017
Blikslager AT.No abstract available
[Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2011].
Schweizer Archiv fur Tierheilkunde    November 29, 2012   Volume 154, Issue 12 513-519 doi: 10.1024/0036-7281/a000400
Müntener CR, Bruckner L, Kupper J, Althaus F, Caduff-Janosa P.167 adverse reactions of Swissmedic-authorized veterinary medicinal products were reported during the year 2011 (2010: 160). Species and drug classes remain comparable with previous years: most of the reactions occurred following the use of antiparasitic products (39 %), antiinfectives (20 %) or non-steroidal antiinflammatory drugs (11 %) in companion animals (85 dogs and 27 cats) followed by cattle/calves (37). We received 15 cases of adverse reactions following reconverted use, 8 of them in treated cats. Additionally the Swiss Toxicological Information Centre in Zürich processed 84 enquirie...
Where does it hurt?
Equine veterinary journal    October 31, 2012   Volume 44, Issue 6 627-628 doi: 10.1111/j.2042-3306.2012.00661.x
Barr AR.No abstract available
Pharmacokinetics of macrolides in foals.
Journal of veterinary pharmacology and therapeutics    October 22, 2012   Volume 36, Issue 1 1-13 doi: 10.1111/jvp.12010
Villarino N, Martín-Jiménez T.Macrolides are used for treatment of pneumonia and extrapulmonary conditions caused by Rhodococcus equi. In foals, macrolides have an extraordinary capacity to accumulate in different lung tissue compartments. These drugs show unique pharmacokinetic features such as rapid and extensive distribution and long persistence in pulmonary epithelial lining fluid (PELF) and bronchoalveolar lavage (BAL) cells from foals. This article reviews the pharmacokinetic characteristics of erythromycin, azithromycin, clarithromycin, tulathromycin, telithromycin, gamithromycin, and tilmicosin in foals, with empha...
[New drugs for horses and production animals in 2011].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    October 19, 2012   Volume 40, Issue 5 301-308 
Emmerich IU.In 2011, three newly developed active pharmaceutical ingredients for horses and food producing animals were released on the German market for veterinary drug products. Two of these new products represent different drug classes of antibiotics, the polypeptide antibiotic Bacitracin (Bacivet™) and the macrolide antibiotic Clorsulon (Levatum®). The third product represents an anticestodal antiparasitic (Tildipirosin, Zuprevo®). Furthermore, three established veterinary active pharmaceutical ingredients were modified to allow their application for additional species. Thus the nonsteroidal anti-...
Pharmacokinetics and adverse effects of oral meloxicam tablets in healthy adult horses.
Journal of veterinary pharmacology and therapeutics    October 15, 2012   Volume 36, Issue 4 376-381 doi: 10.1111/jvp.12021
Vander Werf KA, Davis EG, Kukanich B.The objective of this study was to assess the pharmacokinetic profile and determine whether any adverse effects would occur in seven healthy adult horses following oral meloxicam tablet administration once daily for 14 days at a dose of 0.6 mg/kg·bwt. Horses were evaluated for health using physical examination, complete blood count, serum chemistry, urinalysis, and gastroscopy at the beginning and end of the study. Blood was collected for the quantification of meloxicam concentrations with liquid chromatography and mass spectrometry. The mean terminal half-life was 4.99 ± 1.11 h. There was n...
Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.
Journal of chromatography. A    September 23, 2012   Volume 1265 57-69 doi: 10.1016/j.chroma.2012.09.043
Ho EN, Kwok WH, Lau MY, Wong AS, Wan TS, Lam KK, Schiff PJ, Stewart BD.A veterinary preparation known as TB-500 and containing a synthetic version of the naturally occurring peptide LKKTETQ has emerged. The peptide segment (17)LKKTETQ(23) is the active site within the protein thymosin β(4) responsible for actin binding, cell migration and wound healing. The key ingredient of TB-500 is the peptide LKKTETQ with artificial acetylation of the N-terminus. TB-500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decrease inflammation. In order to control the misuse of TB-500 in equin...
Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes.
European journal of mass spectrometry (Chichester, England)    September 14, 2012   Volume 18, Issue 4 407-412 doi: 10.1255/ejms.1189
Möller I, Thomas A, Wingender A, Machnik M, Schänzer W, Thevis M.Erythropoietin (EPO) and its recombinant analogues are suspected to be illicitly administered to horses for performance enhancing purposes and, consequently, prohibited in equine sports. Recently, a new erythropoiesis-stimulating agent, peginesatide (Omontys, formerly referred to as Hematide), belonging to the upcoming class of EPO-mimetic peptides, received approval for the treatment of anaemia in humans with chronic kidney disease on dialysis. As the pegylated dimeric peptide of approximately 45 kDa without sequence homology to EPO is not detectable by conventional EPO detection assays, spec...
Pharmacokinetics of methylprednisolone acetate after intra-articular administration and subsequent suppression of endogenous hydrocortisone secretion in exercising horses.
American journal of veterinary research    August 29, 2012   Volume 73, Issue 9 1453-1461 doi: 10.2460/ajvr.73.9.1453
Menéndez MI, Phelps MA, Hothem EA, Bertone AL.To determine the pharmacokinetics of methylprednisolone (MP) and the relationship between MP and hydrocortisone (HYD) concentrations in plasma and urine after intra-articular (IA) administration of 100 or 200 mg of MP acetate (MPA) to horses. Methods: Five 3-year-old Thoroughbred mares. Methods: Horses exercised on a treadmill 3 times/wk during the study. Horses received 100 mg of MPA IA, then 8 weeks later received 200 mg of MPA IA. Plasma and urine samples were obtained at various times for 8 weeks after horses received each dose of MPA; concentrations of MP and HYD were determined. Pharmaco...
Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs.
Growth factors (Chur, Switzerland)    June 13, 2012   Volume 30, Issue 4 258-266 doi: 10.3109/08977194.2012.693920
Silver K, Desormaux A, Freeman LC, Lillich JD.Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs for the suppression of inflammation and pain. However, the analgesic properties of NSAIDs are also associated with significant negative side effects, most notably in the gastrointestinal (GI) tract. Increasingly, evidence indicates that the ulcerogenic properties of some NSAIDs are not exclusively the result of inhibition of cyclooxygenase isoforms in the GI tract, and other mechanisms, including inhibition of cell migration and epithelial restitution, are being explored. Recently, microarray analysis was used ...
1 8 9 10 11 12 36